Bio‐Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‐of‐its‐kind integrated workflow for the characterization of charge and size variants in bispecific antibodies and biosimilars.